Orchestra BioMed (Nasdaq:OBIO) announced today that it began the rollout of a protocol update for its BACKBEAT study.

Solventum (NYSE:SOLV) shares rose after hours today on second-quarter results that came in ahead of the consensus forecast.

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Route 92 Medical announced today that it filed a patent infringement lawsuit against Balt related to its Tenzing catheter ...

Apreo Health announced today that it closed an oversubscribed $130 million Series B financing round to support its Breathe ...

Instylla announced today that it received FDA premarket approval (PMA) for its flagship Embrace hydrogel embolic system (HES) ...